Carisoprodol
CAS No. 78-44-4
Carisoprodol( Carisoprodol, Soma, Sanoma, Carisoma )
Catalog No. M15960 CAS No. 78-44-4
Carisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarisoprodol
-
NoteResearch use only, not for human use.
-
Brief DescriptionCarisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands.
-
DescriptionCarisoprodol is a centrally acting skeletal muscle relaxant of the carbamate class and produces all the effects associated with barbiturate receptor ligands.
-
In Vitro——
-
In Vivo——
-
SynonymsCarisoprodol, Soma, Sanoma, Carisoma
-
PathwayMembrane Transporter/Ion Channel
-
TargetGAT
-
RecptorGABAR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number78-44-4
-
Formula Weight260.34
-
Molecular FormulaC12H24N2O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(OCC(C)(COC(N)=O)CCC)NC(C)C
-
Chemical Name[2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kumar M, et al. Neuropharmacology. 2015 Apr 18. pii: S0028-3908(15)00136-7.
molnova catalog
related products
-
Pentetrazol
Pentylenetetrazol is a GABA(A) receptor antagonist, kindles model of epilepsy.
-
4-Amino-3-hydroxybut...
Agent for improving learning or memory [US6803366]Gamma Hydroxybutyric Acid, commonly abbreviated GHB, is a therapeutic drug which is illegal in multiple countries.
-
Chloral hydrate
Chloral Hydrate is a synthetic monohydrate of chloral with sedative, hypnotic, and anticonvulsive properties.
Cart
sales@molnova.com